RxDoctor Payments DataLook up a doctor →

Mark McCune, MD

Dermatology · Overland Park, KSNPI 1871607267

Payments from drug & device makers

$1,972,605in general payments, 2019–2025

Across 813 payments — averaging $2426.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB SA$553K
  • Eli Lilly$264K
  • AbbVie$234K
  • Pfizer$178K
  • Incyte Corporation$159K
  • Amgen$123K
  • plus $462K from 31 others
$5,528in research payments, 2019–2025

Across 4 payments — averaging $1381.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$5K
  • Bausch Health US, LLC$750

What the payments were for

  • Travel & lodging$85018%
  • Food & beverage$3,84281%
  • Education$752%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,972,605 in reported general payments places this provider in the 95th percentile of 82 dermatology providers in Kansas.

See all dermatology providers in Kansas

Medicare billing

Part B allowed, 2024
$150,635
Medicare patients
189
Services billed
558

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin162$435
Doxycycline Monohydrate38$259
Prednisone11$18

Paid to pharmacies, not to this prescriber.

Other dermatology in Overland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →